Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LBMH >> well be still my heart .. ;) Last Trade 3.36
that only took what 7 weeks to break out of a 3c *rigidly* held .. er .. trading range .. what a rigged racket ..
the good ole' US Equities be ..
hmmmm
===
Detailed Quote:LBMH
LIBERATOR MEDICAL HOLDINGS INC
3.36Up 0.01 (0.30 %)AS OF 10:04:04AM ET 01/13/2016
Trade Time 10:04:04am ET
Change 0.01
% Change 0.30%
Open 3.34
Day High 3.37 ********
Day Low 3.34
Previous Close
01/12/2016 3.35
52-Week High
02/24/2015 3.90
52-Week Low
07/28/2015 1.96
Price Performance (Last 52 Weeks)
01/12/2016 +7.03%
Volume 71,867
Volume (10 day Average) 157,000
Volume (90 day Average) 259,111
i call this covering below the waters ... think of an iceberg .. so the 18M + of *volume* done via a 3c range
is how *FILTH* .. controls *outcomes* ..
which begs the ? .. how does the obvious continue to elude the DOJ/FBI/SEC and FINRA?
4kids
well that only took 6 weeks .. ;) .. $3.35 LBMH >> Shares Outstanding 53,886,000 Date Open High Low Close Volume Last Trade 3.35
it's *magic* .. lol
6 weeks with LBMH *held* in a *trading* range of 3c (11.20.15 - 12.31.15) .. (3.31 to 3.34) on approx 18.2M *volume*
they've got some brilliant minds working at the Sec .. ;)
01/04/16 3.33 3.35 3.33 3.35 245,857
12/31/15 3.33 3.34 3.33 3.34 91,014
12/30/15 3.32 3.34 3.32 3.33 335,587
12/29/15 3.33 3.33 3.32 3.325 85,992
12/28/15 3.33 3.33 3.32 3.33 60,751
12/24/15 3.32 3.33 3.32 3.33 13,838
12/23/15 3.33 3.33 3.32 3.33 44,777
12/22/15 3.33 3.33 3.32 3.33 169,631
12/21/15 3.33 3.34 3.32 3.32 43,019
12/18/15 3.32 3.34 3.32 3.32 173,788
12/17/15 3.32 3.34 3.32 3.34 219,857
12/16/15 3.32 3.33 3.32 3.33 138,862
12/15/15 3.33 3.33 3.32 3.33 192,320
12/14/15 3.32 3.33 3.32 3.33 185,098
12/11/15 3.32 3.33 3.32 3.33 135,553
12/10/15 3.32 3.33 3.32 3.32 88,829
12/09/15 3.32 3.33 3.32 3.33 118,755
12/08/15 3.32 3.34 3.32 3.32 819,332
12/07/15 3.32 3.33 3.32 3.33 217,667
12/04/15 3.32 3.34 3.32 3.32 188,617
12/03/15 3.32 3.33 3.32 3.32 291,802
12/02/15 3.32 3.33 3.32 3.33 473,137
12/01/15 3.32 3.33 3.31 3.33 422,931
11/30/15 3.31 3.33 3.31 3.31 261,117
11/27/15 3.32 3.33 3.31 3.33 212,523
11/25/15 3.32 3.34 3.32 3.33 789,216
11/24/15 3.33 3.34 3.32 3.32 1,136,911
11/23/15 3.33 3.34 3.33 3.34 1,698,733
11/20/15 3.31 3.34 3.31 3.34 9,590,944
11/19/15 2.50 2.69 2.50 2.66 65,364
Detailed Quote:LBMH
LIBERATOR MEDICAL HOLDINGS INC
3.35Up 0.01 (0.30 %)AS OF 4:02:01PM ET 01/04/2016
Trade Time 4:02:01pm ET
Change 0.01
% Change 0.30%
Open 3.33
Day High 3.35
Day Low 3.33
Previous Close
12/31/2015 3.34
52-Week High
02/24/2015 3.90
52-Week Low
07/28/2015 1.96
Price Performance (Last 52 Weeks)
12/31/2015 +15.17%
Volume 245,857
Volume (10 day Average) 123,825
Volume (90 day Average) 259,155
4kids
Detailed Quote:LBMH Last Trade 3.33
LIBERATOR MEDICAL HOLDINGS INC
3.33Up 0.00 (0.00 %)AS OF 4:02:01PM ET 12/14/2015
Trade Time 4:02:01pm ET
Change 0.00
% Change 0.00%
Open 3.32
Day High 3.33
Day Low 3.32
Previous Close
12/11/2015 3.33
52-Week High
02/24/2015 3.90
52-Week Low
07/28/2015 1.96
Price Performance (Last 52 Weeks)
12/11/2015 +20.22%
Volume 184,658
Volume (10 day Average) 301,774
Volume (90 day Average) 259,434
the *magic* CONtinues .. ;)
Liberator Medical Reports Revenue of $81.6 Million for Its Fiscal Year Ended September 30, 2015, Declares Cash Dividend of Up to $0.0325 per Share
The Company Reports Net Income of $7.3 Million, or $0.14 per Share, for the Year
http://ir.liberatormedical.com/company-news/detail/800
4kids
it's been 2 weeks since Liberator announced their all cash acquisition by CR Bard
spot the obvious .. re: a *maintained* PPS range .. and the *volume* done in aggregate since 11.20.15
Date Open High Low Close Volume
12/04/15 3.32 3.34 3.32 3.32 188,617
12/03/15 3.32 3.33 3.32 3.32 291,802
12/02/15 3.32 3.33 3.32 3.33 473,137
12/01/15 3.32 3.33 3.31 3.33 422,931
11/30/15 3.31 3.33 3.31 3.31 261,117
11/27/15 3.32 3.33 3.31 3.33 212,523
11/25/15 3.32 3.34 3.32 3.33 789,216
11/24/15 3.33 3.34 3.32 3.32 1,136,911
11/23/15 3.33 3.34 3.33 3.34 1,698,733
11/20/15 3.31 3.34 3.31 3.34 9,590,944
Outstanding as of August 3, 2015
Common Stock, $.001
53,454,958
Liberator Medical Set to Join the Russell Global, Russell 3000 and Russell Microcap Indexes on June 27, According to a Preliminary List Posted on June 13
Previous Close
06/20/2014 4.09
52-Week High
01/21/2014 6.00
52-Week Low
06/24/2013 1.23
Detailed Quote:LBMH Last Trade 3.32 Date Open High Low Close Volume
LIBERATOR MEDICAL HOLDINGS INC
3.32Down -0.02 (-0.60 %)AS OF 4:02:01PM ET 11/24/2015
Trade Time 4:02:01pm ET
Change -0.02
% Change -0.60%
Open 3.33
Day High 3.34
Day Low 3.32
Previous Close
11/23/2015 3.34
52-Week High
02/24/2015 3.90
52-Week Low
07/28/2015 1.96
Price Performance (Last 52 Weeks)
11/23/2015 +19.71%
Volume 1,136,794
Volume (10 day Average) 1,157,645
Volume (90 day Average) 218,565
like magic .. ;)
11/24/15 3.33 3.34 3.32 3.32 1,136,794
11/23/15 3.33 3.34 3.33 3.34 1,698,733
11/20/15 3.31 3.34 3.31 3.34 9,590,944
11/19/15 2.50 2.69 2.50 2.66 65,364
4kids
Detailed Quote:LBMH Last Trade 3.34
LIBERATOR MEDICAL HOLDINGS INC
3.34Up 0.00 (0.00 %)AS OF 4:02:01PM ET 11/23/2015
Trade Time 4:02:01pm ET
Change 0.00
% Change 0.00%
Open 3.33
Day High 3.34
Day Low 3.33
Previous Close
11/20/2015 3.34
52-Week High
02/24/2015 3.90
52-Week Low
07/28/2015 1.96
Price Performance (Last 52 Weeks)
11/20/2015 +19.71%
Volume 1,698,733
Volume (10 day Average) 992,082
Volume (90 day Average) 201,554
.. ;) ..
4kids
Detailed Quote:LBMH Last Trade 3.34
LIBERATOR MEDICAL HOLDINGS INC
3.34Up 0.68 (25.56 %)AS OF 4:02:00PM ET 11/20/2015
Trade Time 4:02:00pm ET
Change 0.68
% Change 25.56%
Open 3.31
Day High 3.34
Day Low 3.31
Previous Close
11/19/2015 2.66
52-Week High
02/24/2015 3.90
52-Week Low
07/28/2015 1.96
Price Performance (Last 52 Weeks)
11/19/2015 -4.66%
Volume 9,587,644
Volume (10 day Average) 40,202
Volume (90 day Average) 96,143
that is one hell of nifty *trick* to hold on 9.5M in *volume* .. a PPS range within 3c
incredibly *revealing* .. ;)
US Equities .. rigged ... too bad all those ambulance chasing firms on the hedgies' speed dial .. don't have the same *interest* when a PPS is *held* for MONTHS and YEARS .. ON END .. snicker ..
what a racket ..
thx Liberator .. loved the cash div .. loved mgmt .. and really thank you for the education of watching
a PPS being hammered .. taking the yield up over 8% .. from when i first entered .. and mgmt never
deviating from their focus and *awareness*
4kids
seems lately every acquisition price tag is held in a rigid range
i'm actually more curious about *volume* totals going forward on LBMH thru acq being completed Q1 2016
currently .. as of
LIBERATOR MEDICAL HOLDINGS INC
3.3301Up 0.6701 (25.19 %)AS OF 2:06:21PM ET 11/20/2015
Volume 8,251,520
Volume (10 day Average) 40,202
Volume (90 day Average) 96,143
4kids
I thought it go higher, at least $4
and note the ambulance chasing atty firms on watch .. trolling yet again ..
interesting since LBMH like so many other US Equities has been *abusively* shorted @ the behest of some *entity*
with LBMH's PPS *held* in a rigidly contained range for a dog's age .. last *take UP* of significance pertained
to inclusion in Russell (from memory so i may be off a few .. that was approx 6.00 and over 2 years ago)
funny how this MO tends to happen over and over and over .. and yet it *eludes* the incompetents within the SEC
regardless .. i'm too familiar with the way the crooks operate when it comes to US Equities .. and added to
my stash rather nicely @ the 2.00 range in the last *orchestrated* take DOWN .. which i also noted via this venue
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=115780598
nice news indeed
acquirer .. CR BARD
Detailed Quote:BCR
CR BARD INC
181.79Down -0.17 (-0.09 %)AS OF 9:41:04AM ET 11/20/2015
4kids
Detailed Quote:LBMH Last Trade 3.3305
LIBERATOR MEDICAL HOLDINGS INC
3.3305Up 0.6705 (25.21 %)AS OF 9:33:09AM ET 11/20/2015
Trade Time 9:33:09am ET
Change 0.6705
% Change 25.21%
Open 3.31
Day High 3.339
Day Low 3.31
Previous Close
11/19/2015 2.66
52-Week High
02/24/2015 3.90
52-Week Low
07/28/2015 1.96
Price Performance (Last 52 Weeks)
11/19/2015 -4.66%
Volume 1,923,408
Volume (10 day Average) 40,202
Volume (90 day Average) 96,143
Liberator Medical Holdings to Be Acquired by C. R. Bard for Approximately $181 Million
STUART, FL -- (Marketwired) -- 11/20/15 -- Liberator Medical Holdings, Inc. ("Liberator") (NYSE MKT: LBMH), a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that it has entered into a definitive agreement to be acquired by C. R. Bard, Inc. (NYSE: BCR), for a cash purchase price of $3.35 per fully-diluted share, or approximately $181 million in the aggregate.
The purchase price represents a 36% premium over Liberator's average closing price during the 90 trading days ended November 19, 2015. The transaction is expected to close in the first quarter of 2016, subject to approval by Liberator's shareholders, satisfaction of customary closing conditions and receipt of certain regulatory approvals.
Mark A. Libratore, Liberator's founder and CEO, commented, "We are pleased to reach a milestone in the growth of Liberator by entering into this agreement with C. R. Bard. We expect that this transaction will create attractive long-term synergies and opportunities for our business partners and customers from the combined companies' ability to offer a broader portfolio of products. We plan to continue offering the same high-quality products to our customers in urology, ostomy, diabetes and mastectomy from our existing suppliers, plus an expanded range of additional categories of high-quality products from Bard."
Shareholders owning approximately 38% of Liberator's common stock have executed a voting agreement to vote in favor of the transaction.
JMP Securities LLC served as exclusive financial advisor to Liberator and provided a fairness opinion to Liberator's Board of Directors. Lowenstein Sandler LLP acted as legal advisor to Liberator.
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. Accredited by The Joint Commission, Liberator's unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies including, urological products, ostomy supplies, mastectomy fashions and diabetes supplies. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
About C. R. Bard, Inc.
C. R. Bard, Inc., headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.
Additional Information and Where to Find It
In connection with the proposed acquisition and required shareholder approval, Liberator plans to file with the U.S. Securities and Exchange Commission (SEC) a proxy statement. The proxy statement will be mailed to Liberator's shareholders. LIBERATOR'S SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT MATERIALS CAREFULLY WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE ACQUISITION AND LIBERATOR.
Liberator and its
executive officers and directors may be deemed to be participants in the solicitation of proxies from Liberator's shareholders with respect to the acquisition. Information about Liberator's executive officers and directors and their ownership of Liberator stock is set forth in the proxy statement for the Liberator 2015 Annual Meeting of Shareholders, which was filed with the SEC on August 11, 2015. Shareholders may obtain more detailed information regarding the direct and indirect interests of Liberator and its executive officers and directors in the acquisition by reading the preliminary and definitive proxy statements regarding the acquisition, which will be filed with the SEC.
Shareholders may obtain free copies of the proxy statement and the other documents filed by Liberator with the SEC (when they are available) at the SEC's web site at www.sec.gov. In addition, shareholders may obtain free copies of the proxy statement and other documents filed with the SEC by Liberator by going to Liberator's Investor Relations page on its corporate website at www.ir.liberatormedical.com, by contacting Liberator investor relations by telephone at (772) 287-2414, or by mail at Liberator Medical Holdings, Inc., 2979 SE Gran Park Way, Stuart, Florida 34997, Attention: Investor Relations.
Forward-Looking Statements
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current expectations, the accuracy of which is necessarily subject to risks and uncertainties. These statements are not historical in nature and use words such as "expect," "anticipate," "possible," "project," "intend," "forecast," "plan," "believe" and other similar expressions or words of similar meaning. Risks and uncertainties include, but are not limited to, the satisfaction of closing conditions to the acquisition, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act; the possibility that the acquisition will not be completed or, if completed, not completed in the expected timeframe; the potential that the expected benefits and opportunities of the acquisition may not be realized or may take longer to realize than expected; regulatory limitations on the medical industry in general; working capital constraints; and adverse litigation or government action. A further list and description of these risks, uncertainties and other factors can be found in Liberator's Form 10-K for the fiscal year ended September 30, 2014 and Liberator's subsequent filings with the SEC. Liberator undertakes no obligation to update its forward-looking statements, whether as a result of new information, future results or otherwise.
Individual Investor Relations Contact
WSR Communications
772-219-7525
IR@WSRcommunications.com
Institutional Investor Contact
Robert J. Davis
Liberator Medical Holdings, Inc.
772-463-3737
bdavis@liberatormedical.com
Source: Liberator Medical Holdings, Inc.
Released November 20, 2015
Note to self.....wonder how much internet promoters are paid these days hmmmmm.....
yeah .. i can see why colluding entities would be *upset*
after LBMH has been *held* in the same price range for a dog's age
without a successful shake of *investors* with Liberator's *mgmt*
continually adding to their stash/revs increasing YOY and that rather
sweet div done quarterly
such probs .. ;)
4kids
LBMH >> Singular Research initiates coverage for LIBERATOR MEDICAL HOLDINGS INC with BUY recommendation.
BY Investars Analyst Actions - public
— 12:03 PM ET 10/29/2015
On October 29, 2015 Singular Research initiated coverage for LIBERATOR MEDICAL HOLDINGS INC (LBMH) with a BUY recommendation.
(above from Fidelity news)
and courtesy of Seeking Alpha (Articles)
http://seekingalpha.com/
Liberator Medical Holdings - Initiating With A BUY Rating
Nov. 6, 2015 2:37 PM ET | About: Liberator Medical Holdings, Inc. (LBMH)
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
Summary
We initiate coverage with a BUY rating and a $3.60 price target.
Consistent revenue growth for a number of years, with a 5 year CAGR of 25%.
Experienced management team that has executed this identical business model with a similar product.
INVESTMENT THESIS
Liberator Medical Holdings, Inc. (NYSEMKT:LBMH) is a distributor of durable medical supplies, predominantly urological and ostomy supplies. The products that LBMH sells are generally supplies which customers need on an ongoing basis (usually for life), which means there is a recurring nature to the business. Liberator markets to consumers via direct response television and radio advertisements, online advertisements, and through their website. The firm was founded in 2001 by Mark Libratore, and is headquartered in Stuart, FL.
Mr. Libratore previously founded and sold a very successful company called Liberty Medical, and Liberator has followed the same business model with a slightly different product. Liberty Medical was well known for selling diabetes supplies direct-to-consumer via direct response television ads. Mr. Libratore eventually sold Liberty Medical to Polymedica, and stayed on to lead the company to substantial subsequent growth and an eventual sale to Medco for $1.5 billion. Liberty Medical was sold at a fairly early stage in the company's growth. With his second company, Liberator, Mr. Libratore planned to maintain a substantial interest in the company through much more substantial growth. Currently, Mr. Libratore maintains approximately a 37% interest in Liberator's common stock, and the company has a market cap of just under $130 million.
In addition to Mr. Libratore himself, he has brought along a senior management team that is also familiar with the business model, and many of them were with him at Liberty Medical. The company has maintained a robust rate of growth since its founding, and over the past 5 years has approximately tripled revenue from about $25 million in FY:08 to about $75 million in FY:14, for CAGR of about 25%. During most of this time, the company has reinvested substantially all of its cash flow into advertising to drive additional revenue growth. Starting in FY:13 the company made a conscious effort to cut back on ad spending, which did slow revenue growth, but created positive EPS and freed up cash flow to institute a meaningful dividend. At this point in time, the company is growing more modestly, but the revenue growth is still significant and projected at about 10% per annum by us for the next few years. We see EPS as flat to modest growth, with cash generation sufficient to maintain the dividend, but the rest being used to spend on advertising for further growth. Management has done a superb job of managing cash flow over the past few years.
For some time now, management has indicated (during conversations with investors at various times) that their goal is to grow to company to approximately $100 million in annual revenue, and then make a decision as to the future of the company. Given Mr. Libratore's significant interest in the common stock, we see this decision as being aligned with the interests of the shareholders. LBMH had revenue of $74.6 million in FY:14 (Fiscal year ends Sept 30), and we project 9.5% growth to $81.9 in FY:15. Per our projections, LBMH should hit $100 million in annual revenue in FY:17. While we think the company can provide for meaningful dividends and substantial capital appreciation in that time frame, we also believe that the opportunity exists for an even more significant gain through a sale to either a strategic buyer or private equity. In FY:13, the closest competitor to LBMH, Rochester Medical, was sold to Bard for $262 million. While Rochester both manufactured and distributed product, it was similar in size to LBMH, and sold at a substantial premium to revenue and earnings compared to where LBMH trades today. LBMH may also make an attractive target for a private equity buyer as it has stable and recurring cash flow, the opportunity to dial current cash flow up or down by adjusting spending on advertising, and an opportunity to introduce leverage as there is currently no debt on the balance sheet with the exception of a small line of credit.
4kids
LBMH >> 8K FILED Election of Directors:
==
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 11, 2015
LIBERATOR MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
NEVADA
000-05663
87-0267292
(State or other jurisdiction
(Commission
(IRS Employer
Of incorporation)
File Number)
Identification Number)
2979 SE Gran Park Way, Stuart, Florida 34997
(Address of Principal Executive Offices)
(772) 287-2414
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
.
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
.
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
.
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
.
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07
Submission of Matters to a Vote of Security Holders
On September 11, 2015, Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), held its annual meeting of stockholders to (i) elect directors; and (ii) ratify the appointment of its independent registered public accounting firm. A majority of the stockholders entitled to vote at the annual meeting were present at the annual meeting in person or by proxy. The following table shows the number of votes cast for, against, abstentions, and the number of broker non-votes on each matter.
For
Against
Withheld
Broker Non-Vote
Mark A. Libratore
31,951,772
0
135,769
10,754,511
Jeannette Corbett
31,315,758
0
771,783
10,754,511
Tyler Wick
31,772,277
0
315,264
10,754,511
Ruben J. King-Shaw, Jr.
31,719,198
0
368,343
10,754,511
Philip Sprinkle
31,934,572
0
152,969
10,754,511
Ratification of Public Accountants:
For
Against
Abstain
Crowe Horwath LLP
42,555,834
263,120
23,098
Act upon such other business as may properly come before the Annual Meeting
For
Against
Abstain
38,385,733
3,814,640
641,679
Item 8.01
Other Events
On September 11, 2015, Mark A. Libratore, the Company’s President and Chief Executive Officer, addressed the stockholders at the Company’s annual meeting of stockholders in Stuart, Florida. Mr. Libratore’s remarks are filed as Exhibit 99.1 to this Report on Form 8-K.
The information under this caption, “Item 8.01 – Other Events,” including information in any related exhibits, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that Section. This information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01
Financial Statements and Exhibits
(d)
Exhibits
Exhibit No.
Description
99.1
Remarks of President and Chief Executive at the Company’s Annual Stockholders Meeting on September 11, 2015.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
LIBERATOR MEDICAL HOLDINGS, INC.
Registrant
Dated: September 11, 2015
/s/ Mark A. Libratore
Mark A. Libratore, President
http://ir.liberatormedical.com/sec-filings/content/0001078782-15-001447/f8k091115_8k.htm
4kids
all jmo
rip SM (09.11.01)
Liberator Medical Declares Cash Dividend of $0.0325 per Share
This Is the 11th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on September 25, 2015
STUART, FL -- (Marketwired) -- 08/25/15 -- Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on August 25, 2015, its Board of Directors approved a cash dividend of $0.0325 per common share to its shareholders. The dividend will be paid on October 9, 2015, to all shareholders of record as of the close of business on September 25, 2015. This is the eleventh consecutive quarterly cash dividend to be paid by the Company, commencing with the dividend paid in May 2013.
The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a quarterly basis the amount and timing of future dividends based on the Company's operating results, financial condition, capital requirements and general business conditions. The amount and timing of dividends may vary, and the payment of any dividend does not assure that the Company will be able to pay or will declare dividends in the future.
Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link: www.LBMH-IR.com
About Liberator Medical
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. Accredited by The Joint Commission, our Company's unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions.
Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.
Contact:
Individual Investor Relations Contact
WSR Communications
772-219-7525
IR@WSRcommunications.com
wsrcommunications.ir.stockpr.com/liberatormedical
Institutional Investor Contact
Robert J. Davis
Liberator Medical Holdings, Inc.
772-463-3737
bdavis@liberatormedical.com
www.liberatormedical.com
Source: Liberator Medical Holdings, Inc.
Released August 25, 2015
Liberator Medical Reports Revenue of $20.4 Million and Net Income of $1.7 Million, or $0.03 per Share, for the Three Months Ended June 30, 2015
The Company Reports Revenue Growth of 9.7% for the Three Months Ended June 30, 2015, Compared to the Same Period in 2014
STUART, FL -- (Marketwired) -- 08/10/15 -- Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced the financial results for its fiscal third quarter ended June 30, 2015.
Net sales for the three months ended June 30, 2015, increased by $1,798,000, or 9.7%, to $20,376,000, compared with net sales of $18,578,000 for the three months ended June 30, 2014. Net sales for the nine months ended June 30, 2015, increased by $5,432,000, or 9.9%, to $60,266,000, compared with net sales of $54,834,000 for the nine months ended June 30, 2014. The increase in net sales was primarily due to our continued emphasis on our direct response advertising campaign to acquire new customers and our emphasis on customer service to maximize the reorder rates for our recurring customer base.
http://ir.liberatormedical.com/company-news/detail/797
http://ir.liberatormedical.com/sec-filings/content/0001078782-15-001244/f10q063015_10q.htm
==
i do and i just added another round recently when 52 week low was *reset* ..
i think Liberator Medical were bounced out of the Russell 3000 .. but remained within Russell Microcap @ the EO June
be interesting to see what the next couple of Qs .. bring
4kids
all jmo
Checking in to see if anyone still has any interest in this. Wow it is back to the price I first bought in at (2.15) back in 2013 when they uplisted to the NYSE MKT. Wonder if it going back down to a dollar?
Do you still own shares? I know you were collecting the dividend.
Liberator Medical Declares Cash Dividend of $0.0325 per Share
This is the 10th Consecutive Quarterly Cash Dividend and is to be Paid to Shareholders of Record at the Close of Business on June 26, 2015
STUART, FL -- (Marketwired) -- 05/29/15 -- Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on May 29, 2015, its Board of Directors approved a cash dividend of $0.0325 per common share to its shareholders. The dividend will be paid on July 10, 2015, to all shareholders of record as of the close of business on June 26, 2015. This is the tenth consecutive quarterly cash dividend to be paid by the Company, commencing with the dividend paid in May 2013.
The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a quarterly basis the amount and timing of future dividends based on the Company's operating results, financial condition, capital requirements and general business conditions. The amount and timing of dividends may vary, and the payment of any dividend does not assure that the Company will be able to pay or will declare dividends in the future.
Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link: http://www.LBMH-IR.com
About Liberator Medical
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. Accredited by The Joint Commission, our Company's unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.
Contact:
Individual Investor Relations Contact
WSR Communications
772-219-7525
IR@WSRcommunications.com
wsrcommunications.ir.stockpr.com/liberatormedical
Institutional Investor Contact
Robert J. Davis
Liberator Medical Holdings, Inc.
772-463-3737
bdavis@liberatormedical.com
www.liberatormedical.com
Source: Liberator Medical Holdings, Inc.
Released May 29, 2015
Liberator Medical Reports Revenue of $19.7 Million and Net Income of $1.7 Million, or $0.03 per Share, for the 3 Months Ended March 31, 2015
The Company Reports Revenue Growth of 11.7% for the Three Months Ended March 31, 2015, Compared to the Same Period in 2014
STUART, FL -- (Marketwired) -- 05/11/15 -- Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced the financial results for its fiscal second quarter ended March 31, 2015.
Net sales for the three months ended March 31, 2015, increased by $2,055,000, or 11.7%, to $19,674,000, compared with net sales of $17,619,000 for the three months ended March 31, 2014. Net sales for the six months ended March 31, 2015, increased by $3,634,000, or 10.0%, to $39,890,000, compared with net sales of $36,256,000 for the six months ended March 31, 2014. The increase in net sales was primarily due to Liberator's continued emphasis on its direct response advertising campaign to acquire new customers and its emphasis on customer service to maximize the retention of its existing customers.
http://ir.liberatormedical.com/company-news/detail/795/liberator-medical-reports-revenue-of-19-7-million-and-net-income-of-1-7-million-or-0-03-per-share-for-the-3-months-ended-march-31-2015
4kids
all jmo
Partner
Balch & Bingham LLP
Atlanta, GA
Email
Philip Sprinkle is partner in the Atlanta office and Chairs the Health Law Practice Group. Having been in private practice since 1981, Mr. Sprinkle is licensed in Georgia, Virginia and Florida and is one of the few Board Certified Health Lawyers in the State of Florida. He is and has only been AV rated. Mr. Sprinkle is a frequent lecturer and writer on health care and corporate matters from taxable and tax-exempt financing to medical staff matters to academic medicine. His speaking engagements include nationally recognized entities such as the American Bar Association, the American Health Lawyer�s Association and the Georgetown Corporate Counsel Institute and numerous state organizations such as the Health Care Financial Management chapters in Virginia and Florida and the Health Lawyers Division of the Virginia State Bar. Mr. Sprinkle is also an Adjunct Professor of Law at the University of Miami where he teaches Health Care Finance and Regulation. Mr. Sprinkle graduated with honors from the University of Virginia College of Arts & Sciences in 1978 and the University of Virginia School of Law in 1981
Liberator Medical Names Philip M. Sprinkle to Board >LBMH
DJ REALTIME NEWS – 4:32 PM ET 10/31/2014
Liberator Medical Names Ruben Jose King-Shaw, Jr., to Board
DJ REALTIME NEWS – 4:32 PM ET 10/31/2014
8K filed
Item 5.02
Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
On October 31, 2014, the Board of Directors (the “Board”) of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), following the recommendation of the Corporate Governance and Nominating Committee of the Board, elected Ruben Jose King-Shaw, Jr., and Philip Sprinkle, II, to serve as members of the Board until the next annual meeting of shareholders and thereafter until their successors have been duly elected and qualified. Mr. King-Shaw will serve on the Audit Committee and the Compensation Committee. Mr. Sprinkle will serve as the Chairman of the Corporate Governance and Nominating Committee.
There are no arrangements or understandings between Messrs. King-Shaw or Sprinkle or any other person pursuant to which either of them was elected as a director. There are no transactions in which either Mr. King-Shaw, Jr., or Mr. Sprinkle has an interest requiring disclosure under Item 404(a) of Regulation S-K of the Securities Act of 1933, as amended (the “Securities Act”). Both new directors will be compensated in the same manner as the Company’s other non-employee directors.
Item 8.01
Other Events
On October 31, 2014, the Company issued a press release announcing the appointment of Messrs. King-Shaw, Jr., and Sprinkle as Directors of the Company. A copy of the press release is attached hereto as Exhibit 99.1.
The information under the caption, “Item 8.01 – Other Events,” including information in any related exhibits, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. This information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10277742
4kids
all jmo
LBMH >> 10.20.14 >> remarks from the shareholders' meeting ..
Exhibit 99.1
Remarks of President and Chief Executive at the Company’s
Annual Stockholders Meeting on October 20, 2014
As I begin to speak about Liberator I must remind you that today's comments may contain forward-looking statements and refer those present to the language regarding forward-looking statements in our SEC reports and press releases. In addition, any financial results disclosed for fiscal year 2014 are unaudited and subject to adjustment, pending the completion of our year-end audit, which is expected to be completed within the next forty-five days.
Over the last year we have witnessed significant change in the healthcare markets we serve. We experienced continued pressure on commercial insurance reimbursement and expanded auditing and cost containment measures by the Centers for Medicare and Medicaid Services. We have seen continued consolidation within the Medical Supply industry and an overall reduction in the number of home medical equipment providers. These trends have taken place against the backdrop of an aging population, expanding chronic disease, increasing demand for medical products and supplies and expanding health coverage for U.S. households. Overall we believe the dynamic of this market presents opportunities for Liberator.
Although we are still in the process of closing the books on fiscal year 2014 I can report that annual sales increased by approximately 7.9% year over year. The increase in sales is attributable to increased advertising expenditures, which we anticipate will continue to yield new customers into the future. In fiscal 2014 we made significant investments in staff training and education to improve the conversion of prospects and retention of customers. Investments in systems and processes continued to facilitate productivity improvements, resulting in flat to slightly reduced labor costs through the fiscal third quarter. We expanded the number of insurance plans we participate with, including the addition of agreements with Anthem Wellpoint and Aetna, the second- and third-largest commercial insurers in covered lives. To date, we have secured participation in over 30 of the major Marketplace Exchange plans and will continue our efforts to secure the remaining smaller plans.
In fiscal 2014 we paid out $6.3 million in dividends compared with $2.6 million in fiscal 2013. As of September 30, 2014, we had approximately $12.3 million of cash on hand versus $12.5 million at the end of fiscal 2013.
In the first quarter our shares were listed on the NYSE MKT, which we believe has expanded the appeal of and access to the company’s shares. In the third quarter our shares were selected for listing on the Russell Global, Russell 3000 and Russell Microcap indexes, exposing Liberator to a wider range of investors.
Looking forward to fiscal 2015, we continue to see opportunities to increase our marketing reach and grow sales through our direct response advertising campaigns. We will continue to evaluate potential acquisitions and selectively invest our resources. We will focus on our customers and improve their experience with Liberator. We will drive productivity through technological and system enhancements and focus on creating positive returns for our shareholders.
This concludes my remarks and at this time I will take questions from the shareholders present today.
http://ih.advfn.com/p.php?pid=nmona&article=64106469&symbol=LBMH
Whatever Mark Libratore touches, turns to gold. First, Polymedica NYSE, now Liberator....they're Florida HQ looks like Disneyland...
LBMH >> proxy materials arrived re: AGM/SHM to be held on 10.20.14
4kids
all jmo
Detailed Quote:LBMH Last Trade 3.19
LIBERATOR MEDICAL HOLDINGS INC
3.19Up 0.01 (0.31 %)AS OF 4:00:54PM ET 09/09/2014
Trade Time 4:00:54pm ET
Change 0.01
% Change 0.31%
Open 3.16
Day High 3.24
Day Low 3.155
Previous Close
09/08/2014 3.18
52-Week High
01/21/2014 6.00
52-Week Low
10/09/2013 1.82
Price Performance (Last 52 Weeks)
09/08/2014 +71.89%
Volume 265,917
Volume (10 day Average) 287,034
Volume (90 day Average) 212,171
link back for historical and div info
4kids
all jmo
Detailed Quote:LBMH Last Trade 3.18
LIBERATOR MEDICAL HOLDINGS INC
3.18Up 0.11 (3.58 %)AS OF 4:02:08PM ET 09/08/2014
Trade Time 4:02:08pm ET
Change 0.11
% Change 3.58%
Open 3.08
Day High 3.19
Day Low 3.05
Previous Close
09/05/2014 3.07
52-Week High
01/21/2014 6.00
52-Week Low
10/09/2013 1.82
Price Performance (Last 52 Weeks)
09/05/2014 +66.85%
Volume 168,346
Volume (10 day Average) 286,347
Volume (90 day Average) 211,724
t$3.24 100 NSD 16:27:30
i$3.18 9 NDD 16:26:18
i$3.05 80 NDD 16:11:10
i$3.19 1 EDGX 16:02:34
6$3.18 5,735 AMX 16:02:08
$3.18 100 NDD 15:59:59
$3.18 100 NDD 15:59:59
i$3.18 25 ARCA 15:59:59
$3.18 172 ARCA 15:59:59
i$3.18 3 ARCA 15:59:59
i$3.19 92 AMX 15:59:59
i$3.18 3 AMX 15:59:55
i$3.19 35 NDD 15:59:53
$3.185 100 BATY 15:59:53
i$3.185 4 BOS 15:59:50
i$3.185 96 BOS 15:59:50
i$3.18 6 EDGA 15:59:46
i$3.185 4 BOS 15:59:38
f$3.189 100 NDD 15:59:38
i$3.19 73 BATY 15:59:31
$3.18 161 BOS 15:59:30
$3.18 200 NDD 15:59:19
$3.18 200 NDD 15:59:19
$3.18 100 NDD 15:59:10
$3.18 500 NDD 15:59:09
$3.1801 1,000 NDD 15:59:09
i$3.1801 80 NDD 15:59:09
$3.1801 200 NDD 15:59:09
$3.1801 200 NDD 15:59:09
i$3.1801 20 NDD 15:59:09
i do expect to see LBMH laddered up back half of the year ..
may not start till Sept tho' .. we'll see
keeping a core holding >> for the divs .. and trading remainder ..
Detailed Quote:LBMH Last Trade 3.07 Year Quarter Announcement Date Open High Low Close Volume Date Open High Low Close Volume Date Open High Low Close Volume
LIBERATOR MEDICAL HOLDINGS INC
3.07Up 0.02 (0.66 %)AS OF 4:00:31PM ET 09/05/2014
Trade Time 4:00:31pm ET
Change 0.02
% Change 0.66%
Open 3.03
Day High 3.10
Day Low 3.01
Previous Close
09/04/2014 3.05
52-Week High
01/21/2014 6.00
52-Week Low
10/09/2013 1.82
Price Performance (Last 52 Weeks)
09/04/2014 +69.44%
Volume 230,675
Volume (10 day Average) 318,741
Volume (90 day Average) 210,532
just a little *volume* on 8.20.14 ;)
congrats to all who know the *rigged* game (drill) and bought LBMH
sub 3.00 .. :)
on 8.20.14 .. why you ask?
because they >> can
interesting to note the last flings out of mgmt in August
8-K Aug 21, 2014 Aug 20, 2014
8-K Aug 18, 2014 Aug 14, 2014
10-Q Aug 14, 2014 Jun 30, 2014
LBMH >> DIVS
Date Ex-Dividend
Date Record Date Pay Date Dividend Amount
($) Dividend Type
2014 Q3 08/20/2014 09/24/2014 09/26/2014 10/10/2014 0.0325 Regular
2014 Q2 06/02/2014 06/24/2014 06/26/2014 07/10/2014 0.03 Regular
2014 Q1 02/03/2014 03/24/2014 03/26/2014 04/10/2014 0.03 Regular
2013 Q4 11/13/2013 12/23/2013 12/26/2013 01/10/2014 0.03 Regular
2013 Q3 08/30/2013 09/24/2013 09/26/2013 10/10/2013 0.03 Regular
2013 Q3 06/14/2013 07/03/2013 07/08/2013 07/22/2013 0.03 Regular
2013 Q2 04/03/2013 04/18/2013 04/22/2013 05/06/2013 0.02 Special
HISTORICAL .. AUGUST 2014 .. LBMH
08/29/2014 2.93 2.98 2.91 2.95 293,289
08/28/2014 2.95 3 2.94 2.94 343,778
08/27/2014 2.94 3.06 2.915 2.96 147,910
08/26/2014 2.9 3 2.84 3 304,711
08/25/2014 2.91 2.98 2.9054 2.93 203,487
08/22/2014 2.87 2.9499 2.83 2.89 161,476
08/21/2014 2.74 2.92 2.72 2.86 554,618
08/20/2014 2.84 2.9 2.301 2.69 2,058,067
08/19/2014 2.89 2.93 2.85 2.87 77,794
08/18/2014 2.95 2.96 2.86 2.9 133,012
08/15/2014 3.1 3.14 2.86 2.94 235,895
08/14/2014 2.96 3.09 2.96 3.07 144,051
08/13/2014 2.91 2.97 2.9021 2.97 53,241
08/12/2014 2.99 3.04 2.89 2.92 57,636
08/11/2014 2.9 3 2.8868 2.99 64,219
08/08/2014 2.89 2.98 2.84 2.93 164,209
08/07/2014 3.06 3.06 2.96 2.98 89,079
08/06/2014 2.98 3.06 2.83 3.02 147,732
08/05/2014 2.98 3.1 2.96 2.99 140,090
08/04/2014 3.04 3.1162 2.95 3 154,696
08/01/2014 3.15 3.17 2.96 3 237,849
HISTORICAL .. JULY 2014 .. LBMH
07/31/2014 3.28 3.39 3.11 3.11 191,750
07/30/2014 3.33 3.39 3.27 3.31 74,826
07/29/2014 3.47 3.5 3.27 3.3 167,641
07/28/2014 3.52 3.57 3.44 3.46 44,257
07/25/2014 3.51 3.57 3.475 3.5 101,714
07/24/2014 3.57 3.59 3.41 3.57 69,052
07/23/2014 3.59 3.599 3.47 3.56 116,111
07/22/2014 3.49 3.6 3.46 3.58 105,479
07/21/2014 3.39 3.49 3.39 3.46 46,991
07/18/2014 3.43 3.5 3.43 3.49 69,215
07/17/2014 3.45 3.5 3.45 3.48 85,238
07/16/2014 3.48 3.5 3.42 3.46 70,637
07/15/2014 3.45 3.519 3.43 3.46 85,070
07/14/2014 3.5 3.5 3.39 3.45 131,949
07/11/2014 3.35 3.41 3.34 3.37 197,165
07/10/2014 3.4 3.44 3.27 3.37 259,044
07/09/2014 3.53 3.6 3.32 3.4 185,179
07/08/2014 3.67 3.69 3.5 3.5 188,042
07/07/2014 3.75 3.79 3.59 3.68 188,474
07/03/2014 3.68 3.75 3.65 3.71 79,779
07/02/2014 3.74 3.78 3.66 3.69 272,991
07/01/2014 3.75 3.81 3.65 3.76 261,003
HISTORICAL .. JUNE 2014 .. LBMH
06/26/14 4.00 4.05 3.96 4.01 250,275
06/25/14 3.95 4.10 3.95 4.01 160,546
06/24/14 4.00 4.07 3.94 4.05 381,337
06/23/14 4.11 4.11 4.01 4.05 122,783
06/20/14 4.06 4.09 3.97 4.09 225,626
06/19/14 4.10 4.1199 4.05 4.06 158,295
06/18/14 4.02 4.09 4.01 4.07 118,188
06/17/14 4.02 4.09 3.96 4.01 122,990
06/16/14 4.15 4.15 4.02 4.06 65,984
06/13/14 4.05 4.15 3.97 4.13 139,670
06/12/14 3.92 4.03 3.89 4.03 164,879
06/11/14 3.94 3.99 3.90 3.99 174,128
06/10/14 3.95 4.00 3.90 3.96 78,076
06/09/14 3.76 3.95 3.76 3.91 219,731
06/06/14 3.90 3.9299 3.81 3.85 99,044
06/05/14 3.80 3.82 3.78 3.82 118,609
06/04/14 3.76 3.80 3.74 3.80 127,278
06/03/14 3.71 3.77 3.64 3.75 173,986
06/02/14 3.71 3.71 3.62 3.71 85,249
4kids
all jmo
finance.yahoo.com/news/liberator-medical-declares-cash-dividend-205528036.html
It's good to be king!
CEO exercises a warrant for 80,000 shares @ $1.00 - right on the expiration date....
http://ih.advfn.com/p.php?pid=nmona&article=63460102&symbol=LBMH
***LBMH Moving on up! gaping and expecting a nice potential today ***
I didn't. I thought it would be a good price at @2.40 but I didn't have an order in.
Did anybody here buy in the 30s? Huge swing here - heavy volume.
Their Quarterly release is similar to prior.
6% sales growth for the Quarter and for the last 9 months. They have earned $.11 thru .03 and $.04 in this quarter. Lets give them an annual earnings at $.16. Since they are growing at 6% say a 15x = $2.40/share.
At its current price the yield about 4% which is pretty good so I don't see it declining but I don't see any reason to add here.
Like the company, like the Cashflow but its not screaming cheap.
Looks to be way oversold here on overall low volume, company fundamentals still seem to be intact. Drop likely due to overall market correction, going to be taking a position again in this one.
FINRA short sales of NTEK
20140714|NTEK|556984|0|1837252|O
30% of today's volume was short sales!
Go NTEK!!!
i'll be selling a portion of mine @ approx 5.50 :)
i do expect to see LBMH laddered up back half of the year ..
may not start till Sept tho' .. we'll see
keeping a core holding >> for the divs .. and trading remainder ..
glty
4kids
all jmo
Yea it would be nice to see this go back to $6.
i'm thinking my gtc gets filled by tomorrow :)
best of luck re: your stox
4kids
all jmo
Couldn't wait - pulled the trigger at 3.35.
love the timing here ;)
Liberator Medical Declares Cash Dividend of $0.03/Share
BY Midnight Trader
— 5:59 PM ET 06/02/2014
05:59 PM EDT, 06/02/2014 (MT Newswires) -- Liberator Medical Holdings (LBMH) , a durable medical equipment company, announced a cash dividend of $0.03 per share.
This is the sixth quarterly cash dividend to be paid by the Stuart, Florida-based company since May last year, it said.
The dividend will be paid on July 10 to all shareholders of record as of the close of business on June 26.
Shares closed up 0.5% at $3.71 on Monday. The stock has more than tripled over the past 12 months.
Price: 3.71, Change: , Percent Change:
know the *game* >> know the patterns in play .. :)
4kids
all jmo
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
403
|
Created
|
06/22/07
|
Type
|
Free
|
Moderators |
Investment Highlights:
Liberator Medical Holdings , Inc.
2979 SE Gran Park Way
Stuart, FL 34997
United States
Phone: 772-287-2414
Fax: 772-286-7881
Website: http://www.liberatormedical.com or http://www.liberatordirect.com/
OTCBB: LBMH.OB
Overview
Liberator Medical Supply, Inc. (“LMS”), a wholly-owned subsidiary of the Company, is a federally licensed, direct-to-consumer, provider of Medicare Part B Benefits focused on providing medical supplies in a retail environment and via the Internet in the United States. LMS distributes a full range of medical products which address the healthcare needs of our customers.
We market our products directly to consumers primarily through targeted media and direct response television advertising. Our customer service representatives are specifically trained to communicate with Medicare-eligible beneficiaries. Our operating platforms enable us to collect and process required documents from physicians and customers, bill and collect amounts due from Medicare and/or other government agencies and/or third party payors and/or customers.
Executive Summary
Our emphasis continues to be on top line sales growth while controlling our costs in order to sustain profitable growth. For the third quarter of fiscal year 2010, our sales increased by 53%, to $10.6 million, compared with the third quarter of fiscal year 2009. For the nine months ended June 30, 2010, our sales increased by 62%, to $29.4 million, compared with the nine months ended June 30, 2009.
We have been able to significantly grow our sales over the last three fiscal years through the downturn in the U.S. economy. Our growth has been driven by our direct response marketing campaign, primarily through television ads at remnant (discounted) rates. Based on information from our media buying agents, we believe that demand for television time slots within the direct response advertising market has increased over the last nine months, creating a more competitive environment within this medium. Although customer acquisition costs remain at acceptable levels, during the third quarter of fiscal year 2010 we increased our spending significantly in alternative media channels and plan to continue those efforts.
Over the last nine months, we have invested heavily in our infrastructure by adding both personnel and facilities, so that we continue to remain capable of supporting a much higher sales volume. We currently have approximately 50% of each of our facilities available for future growth. We have chosen to build our infrastructure ahead of our advertising spend, which helps us achieve compliance on many fronts and maintain the quality of our customer service. Our cost structure continues to remain flexible enough to adapt to changing market conditions. We can pulse our advertising spend and the expansion of our workforce relatively quickly based on the results of our marketing programs. While our sales have increased during the last nine months, we have been able to decrease our general and administrative costs as a percentage of sales.
We believe we are well positioned to continue to grow our sales and improve profitability over the long term.
Management Team:
http://www.liberatormedical.com/investor-relations.aspx
CEO: Mark Libratore
Outstanding Shares: 44.6 Million
Float: 6.96Million
======================================================================================================================================================================================================================================
Revenue Per Quarter
September 30th, 2012 $16,516,000
December 31st, 2012 $17,551,000
March 31st, 2013 $16,734,000
June 30th, 2013 $17,491,000
Annual Revenue
September 30th, 2010 $40,919,000
September 30th, 2011 $52,698,000
September 30th, 2012 $60,943,000
September 30th, 2013 $69,111,000
======================================================================================================================================================================================================================================
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |